Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · IEX Real-Time Price · USD
14.11
-0.32 (-2.22%)
At close: Mar 28, 2024, 4:00 PM
14.00
-0.11 (-0.78%)
After-hours: Mar 28, 2024, 7:34 PM EDT

Teva Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2001
Cash & Equivalents
3,2262,8012,1652,1771,9751,7829639886,9462,226
Upgrade
Cash & Cash Equivalents
3,2262,8012,1652,1771,9751,7829639886,9462,226
Upgrade
Cash Growth
15.17%29.38%-0.55%10.23%10.83%85.05%-2.53%-85.78%212.04%114.45%
Upgrade
Receivables
3,4083,6964,5294,5815,6765,8227,1287,5235,3505,408
Upgrade
Inventory
4,0213,8333,8184,4034,4224,7314,9244,9543,9664,371
Upgrade
Other Current Assets
1,8301,7212,0611,8441,3911,4592,3673,7632,1362,391
Upgrade
Total Current Assets
12,48512,05112,57313,00513,46413,79415,38217,22818,39814,396
Upgrade
Property, Plant & Equipment
6,1476,1586,4776,8556,9506,8687,6738,0736,5446,535
Upgrade
Goodwill and Intangibles
22,56423,90327,50629,54736,07838,92246,05465,89626,70023,920
Upgrade
Other Long-Term Assets
2,2831,8991,1101,2339781,0991,5061,8602,5911,569
Upgrade
Total Long-Term Assets
30,99431,96035,09337,63544,00646,88955,23375,82935,83532,024
Upgrade
Total Assets
43,47944,01147,66650,64057,47060,68370,61593,05754,23346,420
Upgrade
Accounts Payable
2,6021,8871,6861,7561,7181,8532,0692,1571,9183,171
Upgrade
Current Debt
1,6722,1091,4263,1882,3452,2163,6463,2761,5851,761
Upgrade
Other Current Liabilities
7,9737,4737,9158,2209,61110,25312,20613,0559,5027,357
Upgrade
Total Current Liabilities
12,24711,46911,02713,16413,67414,32217,92118,48813,00512,289
Upgrade
Long-Term Debt
18,48119,45222,03323,21024,99726,70028,82932,5248,3588,566
Upgrade
Other Long-Term Liabilities
4,6254,4923,3623,2053,7363,8675,1207,0522,9432,210
Upgrade
Total Long-Term Liabilities
23,10623,94425,39526,41528,73330,56733,94939,57611,30110,776
Upgrade
Total Liabilities
35,35335,41336,42239,57942,40744,88951,87058,06424,30623,065
Upgrade
Total Debt
20,15321,56123,45926,39827,34228,91632,47535,8009,94310,327
Upgrade
Debt Growth
-6.53%-8.09%-11.13%-3.45%-5.44%-10.96%-9.29%260.05%-3.72%-15.29%
Upgrade
Retained Earnings
-13,534-12,975-10,529-10,946-6,956-5,958-3,80313,60714,85114,436
Upgrade
Comprehensive Income
-2,697-2,838-2,683-2,399-2,312-2,459-1,853-3,159-1,955-1,343
Upgrade
Shareholders' Equity
7,5067,80410,27810,02613,97214,70717,35933,33729,76923,313
Upgrade
Net Cash / Debt
-16,927-18,760-21,294-24,221-25,367-27,134-31,512-34,812-2,997-8,101
Upgrade
Net Cash Per Share
-15.13-16.90-19.24-22.12-23.25-26.58-31.02-36.22-3.47-9.44
Upgrade
Working Capital
2385821,546-159-210-528-2,539-1,2605,3932,107
Upgrade
Book Value Per Share
6.717.039.339.1612.8114.4017.0934.9134.8227.33
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).